Table 1.
Summary of papers reporting on CBF measurements in healthy children.
| References | Method | n | Age | CBF (ml/100 g/min) | Age of peak CBF | Subjects |
|---|---|---|---|---|---|---|
| Settergren et al. (17) | 10% NO | 70 | 11 days−15 y | Mean 65 | – | Before elective surgery |
| Ogawa et al. (19) | Xenon injection | 16 | 5–15 year | 92.1 ± 21.5 | – | |
| Chiron et al. (23) | Xe-133 and SPECT | 42 | 2 day−19 year | 50–71 | 5 year | Neurological problems |
| Takahashi et al. (18) | PET | 24 | 10 day−16 year | – | 7 year | Moyamoya, craniosynostosis |
| Vivalala (22) | TCD | 9 | 12–17 | 75.2 ± 15.2 | Healthy volunteers | |
| Wintermark (24) | CT-perfusion | 53 | 7 day−18 year | 40-130-50 | 2–4 year | TBI, headache, seizure, meningitis, those with normal CT were included |
| Satterthwaite et al. (29) | MRI-ASL | 922 | 8–22 year | – | <10 year | Healthy |
| Carsin-Vu et al. (26) | MRI-ASL | 84 | 6 month−15 year | 50–69 | 2–3 year | Headache, seizures |
| Paniukov et al. (27) | MRI-ASL | 96 | 2–7 year | – | 7 year | Healthy |